Nature Publishing Group, publisher of Nature, and other science journals and reference works NATURE.COM NATURE NEWS NATUREJOBS NATUREEVENTS ABOUT NPG
Help Nature.com site index  
Gene Therapy
SEARCH     advanced search my account e-alerts subscribe register
Journal home
Advance online publication
Current issue
Archive
Press releases
For authors
For referees
Contact editorial office
About the journal
For librarians
Subscribe
Advertising
naturereprints
Contact NPG
Customer services
Site features
NPG Subject areas
Access material from all our publications in your subject area:
Biotechnology Biotechnology
Cancer Cancer
Chemistry Chemistry
Dentistry Dentistry
Development Development
Drug Discovery Drug Discovery
Earth Sciences Earth Sciences
Evolution & Ecology Evolution & Ecology
Genetics Genetics
Immunology Immunology
Materials Materials Science
Medical Research Medical Research
Microbiology Microbiology
Molecular Cell Biology Molecular Cell Biology
Neuroscience Neuroscience
Pharmacology Pharmacology
Physics Physics
Browse all publications
 
April 1999, Volume 6, Number 4, Pages 667-675
Table of contents    Previous  Abstract  Next   Full text  PDF
Paper
Efficient CFTR expression from AAV vectors packaged with promoters - the second generation
D Wang1,2, H Fischer3, L Zhang1,2, P Fan1, R X Ding1 and J Dong1,2,a

1Department of Laboratory Medicine, University of California, San Francisco, CA, USA

2Departments of Microbiology and Immunology, and Medicine, The Medical University of South Carolina, Charleston, SC, USA

3Children's Hospital of Oakland, Oakland, CA, USA

aCorrespondence: J Dong, The Medical University of South Carolina, Departments of Microbiology and Immunology, and Medicine, BSB 201, 173 Ashley Avenue, Charleston, SC 29425-2230, USA

Abstract

Gene therapy studies of cystic fibrosis (CF) have shown that AAV-based vector was efficient in transferring but not in expressing the CFTR cDNA in the target cells. The levels of CFTR gene expression were limited by the small packaging capacity of AAV because it had been difficult to package the CFTR cDNA with an efficient promoter. In the present study we have developed a new generation of AAV/CFTR vectors which contain efficient short promoters to express the CFTR gene in target cells. To do so, we reduced the size of the CFTR cDNA by determining the minimal untranslated regions required for expression of CFTR cDNA. We also identified short and efficient promoters that could be packaged with the down-sized CFTR cDNA into a novel AAV vector that had a maximal packag- ing capacity. Functional analyses showed that the new vectors were packaged efficiently and expressed higher levels of CFTR than a vector in which the CFTR gene was driven by the ITR sequence of AAV. Transduction of airway epithelial cells containing 508 mutation with the new vectors demonstrated efficient expression of the wild-type CFTR and correction of the CF phenotype. In contrast, no significant CFTR expression was detected in cells infected with the vector that express the CFTR gene from the ITR. These findings support the notion that the AAV can be developed into an efficient vector to transduce the CFTR gene and vectors expressing higher levels of CFTR from an efficient promoter should provide better efficacy for gene therapy of cystic fibrosis.

Keywords

CFTR; cystic fibrosis; AAV vector; gene therapy; expression

Received 29 June 1998; accepted 28 October 1998
April 1999, Volume 6, Number 4, Pages 667-675
Table of contents    Previous  Abstract  Next   Full text  PDF
Privacy Policy © 1999 Nature Publishing Group